Isaac Barchas Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 2 days, 6 hours ago
Isaac Barchas has an estimated net worth of at least $69.0 million*, as of July 1, 2026. They own 354,519 shares of IMNM stock. They have sold 584,250 shares of IMNM stock since 2021, for an estimated $8.3 million.
Isaac Barchas $IMNM SEC Form 4 Insider Trading
Isaac Barchas has filed a total of 5 insider trades in $IMNM since 2021. Their most recent trade was a sale of 101,050 shares, made on Jun 30, 2026. Their largest trade was a sale of 371,949 shares, made on Dec 22, 2025. We estimate that they now own 354,519 shares of $IMNM, worth an estimated $60.6 million.
Insider Trading at $IMNM
There have been a total of 48 insider trades reported at $IMNM since 2021, with 959,889 shares purchased and 867,092 shares sold. The most active insider traders in $IMNM stock have been Clay B Siegall, Max Rosett, and Robert Lechleider. The most recent trade was a sale of 24,335 shares reported by Isaac Barchas (None), made on Jul 02, 2026.
History of Insider Stock Trades by Isaac Barchas
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
IMNM
|
Sale | 101,050 | Jun 30, 2026 | July 2, 2026, 8:31 p.m. |
|
IMNM
|
Sale | 75,665 | Jul 02, 2026 | July 2, 2026, 8:31 p.m. |
|
IMNM
|
Sale | 24,335 | Jul 02, 2026 | July 2, 2026, 8:31 p.m. |
|
IMNM
|
Sale | 371,949 | Dec 22, 2025 | Dec. 23, 2025, 5:41 p.m. |
|
IMNM
|
Sale | 11,251 | Dec 22, 2025 | Dec. 23, 2025, 5:41 p.m. |
$IMNM Executives and Stock Owners with Insider Trades
-
Clay B Siegall, President and CEO
-
Max Rosett, Chief Financial Officer
-
Robert Lechleider, Chief Medical Officer
-
Jack Higgins, Chief Scientific Officer
-
Philip Tsai, Chief Technology Officer
-
Bruce Turner, Chief Strategy Officer
-
Philip Tsai, Chief Technical Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.